Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation

Efrat Abramson, Clayton Hardman, Akira Shimizu, Soonmyung Hwang, Lynda D Hester, Solomon H Snyder, Paul A. Wender, Paul M. Kim, Michael Kornberg

Research output: Contribution to journalArticlepeer-review


Neuroinflammation characterizes multiple neurologic diseases, including primary inflammatory conditions such as multiple sclerosis (MS) and classical neurodegenerative diseases. Aberrant activation of the innate immune system contributes to disease progression in these conditions, but drugs that modulate innate immunity, particularly within the central nervous system (CNS), are lacking. The CNS-penetrant natural product bryostatin-1 (bryo-1) attenuates neuroinflammation by targeting innate myeloid cells. Supplies of natural bryo-1 are limited but a recent scalable synthesis has enabled access to it and its analogs (termed bryologs), the latter providing a path to more efficacious, better tolerated, and more accessible agents. Here, we show that multiple synthetically accessible bryologs replicate the anti-inflammatory effects of bryo-1 on innate immune cells in vitro, and a lead bryolog attenuates neuroinflammation in vivo – actions mechanistically dependent on PKC binding. Our findings identify bryologs as promising drug candidates for targeting innate immunity in neuroinflammation and create a platform for evaluation of synthetic PKC modulators in neuroinflammatory diseases such as MS.

Original languageEnglish (US)
JournalUnknown Journal
StatePublished - Sep 12 2020


  • Bryolog
  • Bryostatin
  • EAE
  • Innate immunity
  • Multiple Sclerosis
  • Neuroinflammation
  • PKC

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation'. Together they form a unique fingerprint.

Cite this